Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2024-03-07 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
NOTICE OF AGM
Foreign Filer Report
2024-03-07 English
PSP share plan rules - for shareholder approval at 2024 AGM
Remuneration Information Classification · 1% confidence The document text details the 'Plan Rules of the AstraZeneca Performance Share Plan 2020', outlining award vesting criteria, treatment upon termination of employment, change of control provisions, dividend treatment, and tax implications. This document is a formal set of rules governing an employee incentive scheme, specifically related to remuneration and share-based compensation. This aligns most closely with documents detailing executive compensation structures, which falls under the scope of Remuneration Information (DEF 14A) or potentially Governance Information (CGR). However, since it is a detailed plan document specifically about performance shares and executive compensation mechanics, it is a core component of remuneration disclosure. Given the options, 'DEF 14A' (Remuneration Information) is the most specific fit for detailed compensation plan rules, even though it is not a proxy statement itself, it contains the substance typically disclosed in such sections. If the document were a summary or a filing announcing the adoption of this plan, RPA or RNS might apply, but this appears to be the substantive plan text itself. Since the definition for DEF 14A is 'Report detailing compensation for top executives and directors,' and this document details the rules for performance shares (a key compensation tool), I will classify it as DEF 14A. The length (over 53k characters) confirms it is the full document, not a brief announcement.
2024-03-07 English
Proxy Form for 2024 AGM
AGM Information Classification · 1% confidence The document explicitly contains the title 'AstraZeneca PLC: Joining Instructions Annual General Meeting' and a 'Proxy Form: Annual General Meeting'. It details the date, time, and method for joining the AGM, and provides a proxy voting form listing resolutions to be voted upon at that meeting. This content is directly related to the Annual General Meeting (AGM) process and materials.
2024-03-07 English
Notice of AGM
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of AGM" and "Notice of Annual General Meeting 2024 and Shareholders' Circular." It details the date, time, and location of the Annual General Meeting (AGM), provides joining instructions for a digitally-enabled meeting, includes a Letter from the Chair, and lists the specific resolutions to be voted upon at the meeting (including director elections, auditor re-appointment, and remuneration policy approval). This content perfectly matches the definition of AGM Information.
2024-03-07 English
Notice of AGM
AGM Information Classification · 1% confidence The document explicitly states it is a "Notice of Annual General Meeting" and announces the publication of the "Notice of Annual General Meeting 2024 and Shareholders' Circular (the Notice)". It details the date of the AGM (Thursday 11 April) and lists the business to be conducted, which includes receiving accounts, re-appointing the auditor, and approving remuneration policies. This content is directly related to the meeting itself and the materials distributed to shareholders for that meeting. Since the document is an announcement about the AGM and its associated materials, it fits the definition of AGM Information (AGM-R). Although it mentions receiving reports (like the Auditor's Report), the primary purpose of this specific filing is the AGM notice, not the full reports themselves. It is not a DEF 14A (Remuneration Information) because the focus is the meeting logistics and general resolutions, not just compensation details, and it is not a PSI (Proxy Solicitation) as it is the formal notice, not just the proxy material.
2024-03-07 English
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2024-03-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.